Provide insight as to why individuals with
known risk factor variants escape from developing AD
Not exact matches
We currently do not
know how these genetic
risk factors affect the chemistry of the brain and cause specific symptoms, so it is not yet possible for scientists to design drugs to relieve symptoms shown by people with a particular genetic
variant.
Carrying a particular version of the gene for apolipoprotein E (APOE) is the major
known genetic
risk factor for the sporadic, late - onset form of Alzheimer's disease, but exactly how that
variant confers increased
risk has been controversial among researchers.
Three simultaneous reports involving more than 32,000 participants uncovered four new diabetes - associated gene
variants, bringing to 10 the number of
known non-Mendelian genetic
risk factors for type 2 diabetes.
«There are certain genetic
variants that we
know are
risk factors for allergy, but genotyping is not widely used in clinical practice, so this research offers healthcare professionals an alternative method of identifying at -
risk children.»